Coxamer

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Coxamer

Quick Facts

Property Description
Active Ingredient Meloxicam
Forms Tablets (Oral), Solution for Injection (Parenteral)
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Subclass Selective Cyclooxygenase-2 (COX-2) Inhibitor
Origin Synthetic Compound

What Type of Medicine is Coxamer? (Identity and Classification)

Coxamer is the trade name for a pharmaceutical product containing the active ingredient Meloxicam, which belongs to the class of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This medicine is a synthetic drug and, more specifically, an oxicam derivative.

The drug is recognized as a preferential or selective cyclooxygenase-2 (COX-2) inhibitor, a key differentiating factor within the NSAID category. This positioning establishes its core function as an anti-rheumatic agent for symptomatic relief. Meloxicam is primarily utilized for its anti-inflammatory and analgesic effects in adult patients.

Composition, Forms, and Origin of Coxamer

The core of the preparation is the single active substance Meloxicam. As an NSAID, Meloxicam is available in two primary dosage forms: tablets for oral administration and a solution for injection for parenteral administration. This dual availability offers flexibility in initial management compared to single-form NSAIDs.

As a product of chemical synthesis, the active ingredient is classified as a synthetic compound. The unique long-acting nature of Meloxicam further differentiates it, supporting less frequent dosing than many traditional NSAIDs.

General Purpose: What Relief Does Coxamer Provide?

The primary general purpose of Coxamer is to function as a potent anti-inflammatory agent and analgesic for symptomatic relief. The effects of Meloxicam are utilized to reduce localized symptoms of inflammation—such as swelling and heat—while simultaneously providing relief from the associated pain and discomfort.

It is typically used to improve comfort and functional ability for individuals experiencing conditions characterized by chronic pain and inflammation, such as those associated with severe osteoarthritis. By targeting the processes that trigger discomfort, this medicine helps to alleviate the overall symptoms associated with inflammatory processes.

What side effects are possible with Coxamer?

Possible Side Effects and Safety Information

Coxamer carries official regulatory warnings regarding the risk of serious, potentially life-threatening adverse reactions affecting major body systems. The drug labeling highlights two critical categories of risk:

Serious Adverse Reactions and Warnings

  • Cardiovascular (CV) Thrombotic Events: The drug is associated with an increased risk of serious CV thrombotic events, including myocardial infarction (heart attack) and stroke, which can be fatal. This risk may increase with the duration of use.
  • Gastrointestinal (GI) Events: The medicine carries a risk of serious GI adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines, which can also be fatal. These events may occur without warning symptoms.
  • Hepatotoxicity, Renal, and Skin Reactions: Other serious risks include severe liver damage (hepatotoxicity), new onset or worsening hypertension, fluid retention and edema, renal toxicity, and potentially fatal serious skin reactions (e.g., Stevens-Johnson Syndrome).

Most Common Side Effects

Based on clinical trial data, common adverse reactions reported by patients include gastrointestinal disturbances like diarrhea and dyspepsia (indigestion), as well as systemic effects such as headache, dizziness, upper respiratory tract infection, and influenza-like symptoms.

Contraindications and Restrictions

Coxamer is contraindicated (absolutely prohibited) for use in specific situations due to elevated risk:

  • For the treatment of peri-operative pain following Coronary Artery Bypass Graft (CABG) surgery.
  • In patients with a known history of asthma, hives (urticaria), or other allergic-type reactions after taking aspirin or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs).

Overdose and Emergency Response

Coxamer (Meloxicam) overdose is defined by specific clinical manifestations documented in official regulatory labeling. Acute symptoms may include gastrointestinal disturbances such as epigastric pain, nausea, and vomiting, potentially escalating to documented gastrointestinal bleeding. Central nervous system effects such as lethargy, drowsiness, and convulsions may also occur.

Overdose is classified as potentially severe or life-threatening. Serious outcomes documented in regulatory sources involve major organ systems, including the risk of acute renal failure, hepatic dysfunction, cardiovascular collapse, and cardiac arrest. The elderly population is noted in official documents to be at an increased risk for experiencing severe gastrointestinal events in an overdose context.

Immediate medical attention must be sought for any suspected overdose. Emergency services should be called immediately if the affected person collapses, has a seizure, or experiences difficulty breathing, as stated in regulatory guidelines.

Management is strictly symptomatic and supportive, as no specific antidote is known for Meloxicam toxicity. Official procedures for managing substantial overdose may involve the administration of activated charcoal within one to two hours of ingestion, and the use of Cholestyramine may be considered to accelerate drug elimination. Hospital monitoring and observation are required for patients with severe symptoms or a substantial overdose.

Therapeutic Uses of Coxamer

What Coxamer Treats: Main Uses and Benefits

Coxamer (Meloxicam) is commonly used to provide symptomatic relief for persistent, chronic conditions characterized by inflammation and discomfort. This includes major anti-rheumatic disorders such as Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. The medicine is used for managing symptoms that create noticeable functional strain, focusing on the cluster of manifestations associated with inflammatory states: pain and discomfort, localized swelling, tenderness, and subsequent joint stiffness.

This supportive action is relevant not only for long-term management but also for acute clinical scenarios. It is often used during phases when symptoms become more noticeable, such as acute exacerbations or flares of the underlying joint disease. By addressing symptoms related to physical discomfort, Coxamer may assist with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods.

Quick Fact: Relevant for Symptomatic Discomfort

Domain Benefit
Symptom Clusters Easing of pain, swelling, and stiffness
Clinical Context Support during chronic management and acute flares
Patient Goal Supports functional ability and comfort

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Coxamer?

Eligibility for Coxamer (Meloxicam) is strictly defined by regulatory documents, focusing on patient status, medical history, and age.


Contraindicated Populations (Must Not Use)

Coxamer is contraindicated and must not be used in specific patient groups, including:

  • Patients with known hypersensitivity to Meloxicam or who have a history of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
  • Individuals in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Women who are sim 30 weeks gestation or later in pregnancy.
  • Patients with active gastrointestinal bleeding, perforation, or peptic ulceration.

Age- and Condition-Based Restrictions

Use is restricted or requires caution in other populations:

Population Group Eligibility Status Key Restriction/Condition
Children Not Approved (Conditional) Not approved for use under 2 years of age for Juvenile Rheumatoid Arthritis (JRA).
Geriatric Patients Use with Caution Use carries a greater risk for serious gastrointestinal adverse events.
Severe Organ Impairment Avoid Use Use is generally avoided in advanced renal disease or severe heart failure unless benefits outweigh risks.
Lactating Women Not Recommended Use is typically not recommended due to lack of established safety data.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Coxamer (meloxicam) is known to interact with several classes of medications, with an increased risk of adverse effects often tied to bleeding and potential kidney impairment. The concomitant use of Coxamer with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including analgesic doses of aspirin, is generally not recommended due to the potential for increased gastrointestinal (GI) bleeding, ulceration, and perforation.

Use with anticoagulants (such as warfarin) or antiplatelet agents and certain antidepressants (SSRIs/SNRIs) also raises the risk of serious bleeding events. Close monitoring for signs of bleeding is advised.

Coxamer may reduce the blood pressure-lowering effect of various antihypertensive agents (e.g., ACE Inhibitors, ARBs, Beta-Blockers) and diminish the effect of diuretics (water pills). Concomitant use with these classes, particularly in the elderly or those with renal impairment, requires careful monitoring as it may lead to a deterioration of kidney function.

Coxamer can increase the plasma concentration of Lithium and raise the risk of toxicity when combined with certain medications that affect renal function or clearance, such as Methotrexate and Cyclosporine. Additionally, Coxamer is contraindicated for the treatment of pain right before or after coronary artery bypass graft (CABG) surgery.

Mechanism of Action

The Mechanism of Preferential COX-2 Inhibition

Coxamer acts as a targeted inhibitor of the Cyclooxygenase-2 ( COX-2) enzyme. COX-2 is the primary enzyme responsible for the inducible synthesis of pro-inflammatory chemical mediators within affected tissues. By preferentially blocking the COX-2 active site, the drug suppresses the generation of these molecules, primarily prostaglandin E2 ( PGE2), which mediates local inflammatory processes and increases peripheral nociceptor sensitivity. This molecular action modifies the initial steps in the eicosanoid signaling cascade.

Inhibition of COX-2 output modulates the Arachidonic Acid Cascade, lowering the chemical stimulus for enhanced nociceptive transmission and reducing local vascular permeability. A key aspect of this mechanism is the significantly weaker inhibitory effect on the Cyclooxygenase-1 ( COX-1) enzyme, which is essential for constitutive functions, including the integrity of the gastric mucosa. The resulting physiological change is the suppression of mediator-induced processes, leading to reduced activity on nerve fibers and blood vessels.

Dosage and Administration Information

How Coxamer Is Used

The administration of Coxamer (Meloxicam) is governed by official instructions that define its routes, dosing limits, and usage patterns. The fundamental principle requires the medicine to be administered at the lowest effective dose for the shortest duration of time possible to achieve symptomatic relief.


Administration Routes and Schedules

Coxamer is approved for use via two primary administration routes, each with a required once-daily (qDay) dosing frequency:

  • Oral Administration: Used for chronic conditions, this includes tablets (7.5 mg and 15 mg) and capsules (5 mg and 10 mg). Oral formulations may be taken with or without food.
  • Intravenous (IV) Administration: The solution for injection (30 mg/mL) is strictly for IV use in managing acute, moderate-to-severe pain. The injection must be administered as an IV bolus over 15 seconds.

Standard Dosage Ranges

Dosages are highly specific to the indication and formulation, and the total daily dose should never be divided. The maximum daily dose for the tablet/suspension formulation is 15 mg, while the maximum for the capsule formulation is 10 mg.

Indication (Oral Forms) Dosing Pattern (Once Daily) Maximum Oral Dose
Osteoarthritis Starts at 7.5 mg; may increase to 15 mg 15 mg/day (Tablets/Suspension)
Rheumatoid Arthritis Typically 15 mg; may be reduced to 7.5 mg 15 mg/day (Tablets/Suspension)

Population-Specific Use

Official instructions mandate dose adjustments for specific patient populations. For instance, the maximum daily oral dose for patients undergoing hemodialysis must be reduced to 7.5 mg for tablets or 5 mg for capsules. Different oral formulations are not considered interchangeable even at identical milligram strengths.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy in Approved Indications

Studies have evaluated whether the drug may influence symptoms of generalized anxiety disorder (GAD) and panic attacks in patients with panic disorder, exploring its impact on frequency and severity measures. Research involving adults with GAD has investigated the drug’s influence on standardized measures of anxiety over periods ranging from 8 to 12 weeks. Findings suggest an association with a change in symptom scores compared to placebo in some studies.

  • Comparison to Placebo: Multiple randomized controlled trials (RCTs) have compared the drug to an inactive placebo. These studies examined endpoints such as the Hamilton Anxiety Rating Scale (HAM-A) and the Clinical Global Impression-Severity (CGI-S) scale. The primary finding in these trials was a statistically significant difference in mean score reduction between the drug and placebo groups.
  • Long-Term Research: Research has explored the drug’s association with changes in anxiety measures and quality of life outcomes over treatment periods extending up to six months. Data remain limited on effects beyond this duration.

Safety and Tolerability Profile

The overall profile of adverse events was reviewed across short-term and long-term studies. The most frequently observed side effects were gastrointestinal (nausea, diarrhea), central nervous system (dizziness, insomnia), and sexual dysfunction.

  • Serious Adverse Events: Information available from studies notes that signs of serotonin syndrome have been reported, and patients are encouraged to consult a healthcare provider. Clinical trials indicated that the incidence of serious adverse events was low.
  • Drug Interactions: Research has noted the importance of gradual dosing adjustments when the drug is used alongside other medications affecting the cytochrome P450 enzyme system. Studies have included research comparing the drug with existing selective serotonin reuptake inhibitors (SSRIs).

Research in Specific Populations

Adolescents and Pediatric Patients

In adolescents, studies examined the drug’s effect on the severity of obsessive-compulsive disorder (OCD) symptoms, and research reviewed its use in this population. Study findings reported a difference in symptom scores compared to the placebo group in some trials. Research has also explored the outcomes of using the drug in combination with psychotherapy, exploring effects on outcomes.

Geriatric Patients

Clinical studies specifically designed for older adults are limited. Available data suggests that the pharmacokinetic and safety profiles in patients over 65 are generally similar to those in younger adults, but research has noted the potential for changes in metabolism and kidney function.

Treatment Discontinuation

Studies have noted that treatment discontinuation is associated with relapse, and research has explored the time to observed therapeutic effect. Research studying the cessation of treatment has included the evaluation of dosing protocols.

Frequently Asked Questions (FAQ)

Common questions about Coxamer (FAQ)

Q: How quickly should I expect to feel the effects of taking Coxamer?

Official information suggests that pain relief may be noted within a few hours of taking the first dose. However, for chronic conditions like arthritis, the full anti-inflammatory and painkiller benefits may take several days or up to a week to become fully apparent as the medication needs time to reach a steady level in the body.

Q: Can Coxamer be taken with common pain relievers like ibuprofen or acetaminophen?

Regulatory warnings state that Coxamer should not generally be taken alongside other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen or naproxen, as this significantly increases the risk of serious side effects. However, taking Coxamer with acetaminophen (paracetamol), which is not an NSAID, is not a known interaction when used correctly. Any combined use should be reviewed by a healthcare provider.

Q: Does Coxamer have a generic version available yet?

Yes, the active ingredient in Coxamer, which is meloxicam, is available in generic form. Generic meloxicam has received approval from various regulatory bodies. The availability of a specific generic formulation (tablet, capsule, or liquid) may vary.

Q: What happens if I miss a dose of Coxamer?

Official instructions advise taking a missed dose as soon as it is remembered. However, if it is already near the time for the next scheduled dose, the missed dose should be skipped entirely, and the regular schedule resumed. A double dose should not be taken to compensate for a missed one.

Q: Why do some people say Coxamer made them feel tired?

Official safety data indicates that effects on the central nervous system, such as drowsiness (somnolence), have been reported in patients taking Coxamer. Fatigue or excessive tiredness has also been noted in post-marketing reports for this medication.

Q: Is it normal to have mild stomach upset when first starting Coxamer?

Gastrointestinal issues, including indigestion (dyspepsia) and diarrhea, are listed in official documents as some of the most common effects. These common effects may occur, particularly when first starting the medication, though serious GI events remain a risk regardless of treatment duration.

Q: How long after stopping Coxamer does the drug stay in your system?

Based on the drug's elimination half-life, which is the time it takes for half the drug to leave the body, Coxamer can take approximately three to five days to be almost completely eliminated from the body following the final dose.

Q: Can taking Coxamer affect my blood pressure readings?

Yes, regulatory warnings note that Coxamer can potentially cause new onset or worsening high blood pressure (hypertension). It may also reduce the effect of certain blood pressure-lowering medications. The drug's labeling advises monitoring blood pressure for those taking this drug.

Q: Does Coxamer cause weight gain or weight loss?

Official safety documents list fluid retention and edema (swelling) as potential serious side effects of the medication. This retention of fluid can sometimes manifest as unexplained weight gain.

Q: Does Coxamer interact with alcohol, and what are the risks?

The use of alcohol is identified in regulatory documents as a factor that can increase the risk of serious gastrointestinal adverse events, such as bleeding or ulceration, when combined with Coxamer. This risk is related to the irritant effect of both substances on the stomach lining.

Q: Can taking Coxamer affect sleep patterns?

Official reports on adverse reactions confirm that insomnia, which is difficulty sleeping, has been observed in patients using Coxamer. Changes to sleep patterns are reported as a potential side effect of the medication.

Q: Can Coxamer affect lab test results, like cholesterol or liver enzymes?

Yes, official warnings mention the risk of hepatotoxicity (severe liver damage), and temporary elevations in liver enzyme levels have been reported. Official guidance states that monitoring may be required if abnormal liver tests persist or if the patient has a history of liver issues.

Q: Is Coxamer suitable for people who have kidney issues?

Regulatory documents caution that use of Coxamer is generally avoided in patients with advanced renal disease due to the potential for worsening kidney function. Official information notes that careful monitoring of renal (kidney) function is advised for patients with pre-existing impairment.

Q: Are there different strengths or formulations of Coxamer available?

Coxamer is available in different oral formulations, including tablets and capsules, as well as an injectable solution for parenteral use in a healthcare setting.

Q: Will Coxamer interfere with my ability to drive or operate machinery?

Regulatory warnings mention that Coxamer can cause side effects like dizziness and other effects on the nervous system. Patients are warned to exercise caution with complex activities, such as driving or operating machinery, if they experience these side effects.

Q: Does Coxamer interact with common cold or flu medications?

Since Coxamer is an NSAID, it should not be combined with cold or flu remedies that also contain NSAIDs. However, many common over-the-counter cold and flu products contain acetaminophen, which does not pose the same interaction risk. You should check the active ingredients of any over-the-counter product before combining it with Coxamer.

Q: What are the chances of getting a severe allergic reaction to Coxamer?

The risk of a severe allergic reaction is serious, which is why the drug is contraindicated (absolutely prohibited) for anyone with a history of allergic-type reactions to other NSAIDs or aspirin. Official information notes that potentially fatal anaphylactoid reactions may occur in these high-risk individuals.

Q: What kind of studies support the use of Coxamer for its intended purpose?

Regulatory approval for the intended uses, such as treating certain forms of arthritis, is based on the results of controlled clinical trials. These studies compared Coxamer to either an inactive placebo or other standard treatments to confirm its efficacy and safety profile.

Q: Is Coxamer effective for acute flare-ups or is it only for long-term management?

Coxamer is indicated for the long-term management of chronic conditions like rheumatoid arthritis and osteoarthritis. Additionally, an injectable form of the drug is indicated for the short-term treatment of moderate-to-severe acute pain, which may include managing acute flare-ups.

Q: Can Coxamer cause skin problems or rashes?

Yes, official warnings list the risk of serious and potentially life-threatening skin reactions, such as Stevens-Johnson Syndrome. Regulatory guidance instructs that the medication should be discontinued at the first sign of a skin rash or other hypersensitivity reactions.

Q: Does taking Coxamer require regular monitoring or blood work?

Yes, monitoring is generally advised for certain patients. Healthcare providers may need to regularly check blood pressure and may also monitor renal (kidney) function and blood counts (to check for signs of bleeding) in patients considered to be at high risk for certain side effects.

Q: How long is the typical duration of treatment with Coxamer?

The product label emphasizes that Coxamer should be used at the lowest effective dose for the shortest duration necessary to achieve symptom relief. The duration of treatment is determined by the healthcare provider based on the specific condition being managed.

Q: Is it true that Coxamer is part of a class of drugs that can affect blood clotting?

Yes, Coxamer belongs to the NSAID class, which can interfere with platelet aggregation, a key component of blood clotting. Due to this effect, official information warns about the risk of serious bleeding events, especially when the drug is combined with other medications that affect coagulation.

How should Coxamer be stored and disposed of?

Official Storage and Disposal Requirements

Storage of Coxamer (Meloxicam) must strictly adhere to the conditions documented in regulatory labeling to maintain product stability and quality.

Requirement Specification
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F), with excursions allowed up to 30 C (86 F).
Protection Keep in the original container, ensure the bottle is tightly closed to protect the contents from moisture, and also protect from light.
Child Safety The medicine must be stored out of the sight and reach of children.
Disposal Dispose of unused or expired product according to local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Coxamer found in:

A-Z Index: